Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2 M Gheblawi, K Wang, A Viveiros, Q Nguyen, JC Zhong, AJ Turner, ... Circulation research 126 (10), 1456-1474, 2020 | 2199 | 2020 |
Angiotensin converting enzyme 2: a double-edged sword K Wang, M Gheblawi, GY Oudit Circulation 142 (5), 426-428, 2020 | 312 | 2020 |
Dysregulation of ACE (angiotensin-converting enzyme)-2 and renin-angiotensin peptides in SARS-CoV-2 mediated mortality and end-organ injuries K Wang, M Gheblawi, A Nikhanj, M Munan, E MacIntyre, C O’Neil, ... Hypertension 79 (2), 365-378, 2022 | 71 | 2022 |
Sex-and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility A Viveiros, M Gheblawi, PK Aujla, DK Sosnowski, JM Seubert, Z Kassiri, ... Journal of molecular and cellular cardiology 164, 13-16, 2022 | 45 | 2022 |
Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications P Chatterjee, M Gheblawi, K Wang, J Vu, P Kondaiah, GY Oudit Clinical science 134 (17), 2319-2336, 2020 | 39 | 2020 |
Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators KX Fernandez, C Fischer, J Vu, M Gheblawi, W Wang, S Gottschalk, ... RSC Medicinal Chemistry 12 (8), 1402-1413, 2021 | 21 | 2021 |
Optimizing PEG-extended apelin analogues as cardioprotective drug leads: importance of the KFRR motif and aromatic head group for improved physiological activity C Fischer, T Lamer, K Fernandez, M Gheblawi, W Wang, C Pascoe, ... Journal of Medicinal Chemistry 63 (20), 12073-12082, 2020 | 18 | 2020 |
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury A Vergara, K Wang, D Colombo, M Gheblawi, J Rasmuson, R Mandal, ... Clinical Kidney Journal 16 (2), 272-284, 2023 | 12 | 2023 |
SARS-CoV-2 infection downregulates myocardial ACE2 and potentiates cardiac inflammation in humans and hamsters A Viveiros, RS Noyce, M Gheblawi, D Colombo, LM Bilawchuk, ... American Journal of Physiology-Heart and Circulatory Physiology 323 (6 …, 2022 | 12 | 2022 |
Response by Gheblawi et al to Letter Regarding Article,“Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th … M Gheblawi, K Wang, A Viveiros, Q Nguyen, JC Zhong, AJ Turner, ... Circulation Research 127 (2), e46-e47, 2020 | 12 | 2020 |
ACE2 (angiotensin-converting enzyme 2)-mediated protection from pulmonary hypertension: lung-gut axis at center stage M Gheblawi, K Wang, GY Oudit Hypertension 76 (1), 28-29, 2020 | 6 | 2020 |
Testosterone and cardiac remodeling: why are older men susceptible to heart disease? P Zhabyeyev, M Gheblawi, GY Oudit American Journal of Physiology-Heart and Circulatory Physiology 316 (4 …, 2019 | 3 | 2019 |
Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition M Khoramjoo, K Wang, K Srinivasan, M Gheblawi, R Mandal, S Rousseau, ... Plos one 19 (6), e0304522, 2024 | 1 | 2024 |
Loss of ACE2 in a Diabetic Obese Setting Exacerbates Cardiovascular Dysfunction in the Setting of Gut Dysbiosis M Gheblawi, F Wang, R Basu, R Prasad, MB Grant, GY Oudit Circulation 148 (Suppl_1), A13173-A13173, 2023 | 1 | 2023 |
Angiotensin-Converting Enzyme 2 and Urine Amino Acid Excretion Increase in COVID-19 Patients With AKI: FR-PO024 A Vergara, K Wang, D Colombo, M Gheblawi, JC Rasmuson, R Mandal, ... Journal of the American Society of Nephrology 33 (11S), 332, 2022 | | 2022 |
An advanced endothelial murine HFpEF model: eNOS is critical for angiotensin 1-7 rescue of the diabetic phenotype M Gheblawi, AA de Oliveira, VR Williams, R John, MB Grant, JW Scholey, ... Journal of molecular and cellular cardiology 169, 10-12, 2022 | | 2022 |
Role of Epicardial Adipose Tissue in Heart Failure: From Basic to Clinical Perspectives H Zhang, M Gheblawi, JC Zhong, GY Oudit Biochemistry of Cardiovascular Dysfunction in Obesity, 173-194, 2020 | | 2020 |